DCTH - Delcath Systems Inc - Stock screener for investors and traders, financial visualizations. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems Stock (NASDAQ: DCTH) stock price, news, charts, stock research, profile. Delcath Systems (DCTH) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Get the latest Delcath Systems Inc (DCTH) real-time quote, historical performance, charts, and other financial information to help you make more informed.
Historical daily share price chart and data for Delcath Systems since adjusted for splits and dividends. The latest closing stock price for Delcath. Research Delcath Systems' (Nasdaq:DCTH) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver. Get Delcath Systems Inc (DCTH.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange. In the current month, DCTH has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DCTH average Analyst price target in the past 3 months is $ Webull offers DCTH Ent Holdg (DCTH) historical stock prices, in-depth market analysis, NASDAQ: DCTH real-time stock quote data, in-depth charts, free DCTH. Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. Delcath Systems, Inc.'s stock symbol is DCTH and currently trades under NASDAQ. It's current price per share is approximately $ Investor Relations. NASDAQ CM: DCTH. $ + (+%) Sep 4, PM EDT. See Stock Info. Our Mission. To achieve and deliver breakthroughs in therapies.
The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination. DCTH priced its public offering of million shares and additional warrants at a 37% discount to its Thursday closing price. Shares dropped 36% in premarket. Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. DCTH is not. The current price of DCTH is USD — it has increased by % in the past 24 hours. Watch Delcath Systems, Inc. stock price performance more closely on the. View Delcath Systems (DCTH) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with. Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The Delcath Systems Inc stock price today is What Is the Stock Symbol for Delcath Systems Inc? The stock symbol for Delcath Systems Inc is "DCTH." What. Track Delcath Systems Inc (DCTH) Stock Price, Quote, latest community messages, chart, news and other stock related information.
While ratings are subjective and will change, the latest Delcath Systems (DCTH) rating was a reiterated with a price target of $ to $ The current. Delcath Systems Inc DCTH:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/29/24 · 52 Week Low View the real-time DCTH price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. On average, Wall Street analysts predict that Delcath Systems's share price could reach $ by Aug 6, The average Delcath Systems stock price. Delcath is dedicated to revolutionizing the treatment of cancer patients with the newest liver directed treatment for metastatic ocular melanoma.
DCTH - Delcath Systems, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). DCTH has outperformed the market in the last year with a price return of +% while the SPY ETF gained +%. DCTH has also outperformed the stock market. Delcath Systems stock quote and DCTH charts. Latest stock price today and the US' most active stock market forums. View Delcath Systems (DCTH) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with. Delcath Systems Inc. (DCTH). Delcath Systems, Inc NASDAQ: DCTH is an oncology company focused on the treatment of primary and metastatic liver cancers. The. Delcath Systems, Inc.: Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock Delcath Systems, Inc. | Nasdaq. The latest Delcath Systems stock prices, stock quotes, news, and DCTH history to help you invest and trade smarter.
How To Look Up A Company Fein Number | Bape Chain